Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1993-05-24
1996-08-20
Robinson, Douglas W.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
530399, 536 264, 536 2641, C07H 2300, C07K 200
Patent
active
055480640
ABSTRACT:
The invention describes complexes between VB.sub.12 analogues and either GCSF or EPO that retain both significant affinity for intrinsic factor (IF) in the VB.sub.12 portion of the complex and significant bioactivity of the GCSF or EPO portion of the complex. The invention also concerns a process for the synthesis of these complexes. This is achieved at least in part, by using a spacer compound, which is linked covalantly between the VB.sub.12 portion and the GCSF or EPO. The complexes preferably have the formula
REFERENCES:
patent: 3876765 (1975-04-01), Choay
patent: 3962416 (1976-06-01), Katzen
patent: 4007266 (1977-02-01), Choay
patent: 4235869 (1980-11-01), Schwartzberg
patent: 4672040 (1987-06-01), Josephson
patent: 4677195 (1987-06-01), Hewick et al.
patent: 4732889 (1988-03-01), Cynshi et al.
patent: 4745099 (1988-05-01), Akamatsu et al.
patent: 4963367 (1990-10-01), Ecanow
patent: 5026826 (1991-06-01), Evans et al.
patent: 5071834 (1991-12-01), Burton et al.
patent: 5162430 (1992-11-01), Rhee et al
patent: 5206219 (1993-04-01), Desai
patent: 5292802 (1994-03-01), Rhee et al.
patent: 5308889 (1994-05-01), Rhee et al
Chan et al., "Pharmacokinetics and Metabolism of LHRH Analogs," Ch. 37 in LHRH and Its Analogs; Contraception and Therapeutic Applications Part 2, Vickery & Nestor eds., Kluwer Academic Publishers, Norwell, MA, 1987, pp. 577-593.
Kwan et al., "Biopharmaceutics," Ch. 9 in The Theory and Practice of Industrial Pharmacy, Lochman, Lieberman & Kanig eds., Williams and Wilkins, 1986, pp. 197-242.
deKlerk et al., "Serum Erythropoietin (ESF) Titers in Anemia." Blood, 58(6), 1164-1170 (1981).
Neiman et al., "Carcinogenic Agents and Reactions of Organism in Response to Them," Patol. Fiziol. Eksp. Ter., 1972(4), 14-18; Chem. Abstr., 77(25), p. 73, Abstr. No. 160683t (1972); only Abstract supplied.
Babior (ed.), Cobalamin-Biochemistry and Pathophysiology, Wiley-Interscience, New York, 1975, p. 25.
Anton et al. "Carbon-13 Nuclear Magnetic Resonance Studies of the Monocarboxylic Acids of Cyanocobalamin. Assignments of the b--, d--, and e--Monocarboxylic Acids," J. Am. Chem. Soc. 102: 2215-2219 (1980).
Rejmanov a et al. "Polymers Containing Enzymatically Degradable Bonds, 2 Poly[N-(2-hydroxypropyl)methacrylamide]Chains Connected by Oligopeptide sequences. . . ," Makromol. Chem. 182: 1899-1915 (1981).
Russell-Jones Gregory J.
Westwood Steven W.
Biotech Australia Pty Limited
Crane L. Eric
Robinson Douglas W.
LandOfFree
Vitamin B12 conjugates with EPO, analogues thereof and pharmaceu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vitamin B12 conjugates with EPO, analogues thereof and pharmaceu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitamin B12 conjugates with EPO, analogues thereof and pharmaceu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2331491